Wee Kiat Tan, Chief Executive Officer
•Previously co-CEO and COO of NASDAQ-listed biotech, which he built from 1 to 30 people
•Led First in-Human Phase I clinical trial
Abbas El Sahili, Chief Technology Officer
•>30 scientific papers, 3 patents
•10 years experience
•Expertise in peptide ligases
•Expertise in protein engineering
Siew Pheng Lim, Chief Scientific Officer
•>16 years industry experience
•>70 scientific papers, 3 patents
•Expertise in cancer biology
•Expertise in drug discovery